70.90EUR-1.66%Mkt Cap: 895.85M $P/E: 14.351d ago
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offer…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Cheaper
P/B
Avg
Div Yield
Higher
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap895.85M $
Enterprise Value672.05M $
Revenue (TTM)571.40M $
Gross Profit426.98M $
Net Income (TTM)62.35M $
Revenue/Share49.17 USD
Last Price70.90 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.4K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0004186856
Valuation
P/E (Trailing)14.35
P/E (Forward)12.56
PEG3.80
EV/EBITDA5.98
EV/Revenue1.18
P/S1.57
P/B1.47
EPS (TTM)4.94
EPS (Forward)5.64
52W Range
67.3015% of range91.50
52W High91.50 EUR
52W Low67.30 EUR
Profitability
Gross Margin74.73%
Oper. Margin16.82%
EBITDA Margin19.68%
Profit Margin10.91%
ROE9.70%
ROA7.51%
Growth
Revenue Growth-2.40%
Earnings Growth-5.10%
Cash Flow & Leverage
Operating CF78.34M $
CapEx (TTM)22.53M $
FCF Margin9.26%
FCF Yield5.91%
Net Debt-223.68M $
Net Debt/EBITDA-1.99
Balance Sheet
Debt/Equity0.03
Current Ratio3.08
Quick Ratio2.21
Book Value/Sh48.21 EUR
Cash/Share19.02 EUR
Dividends
Fwd Div Rate0.9300 EUR
Trail. Div Rate0.9300 EUR
Div. Yield1.29%
5Y Avg Yield0.86%
Payout Ratio18.02%
Ex-Div DateJun 3, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)90.38 EUR
Upside (mean)+27.5%
Target Range80.00 EUR – 110.00 EUR
€80.00+27.5% to mean€110.00
# Analysts4
Ownership
Shares Out.11.62M
Float3.65M
Insiders67.01%
Institutions13.42%
Technical
SMA 5073.10 (-3.0%)
SMA 20078.06 (-9.2%)
Beta0.89
S&P 52W Chg20.05%
Avg Vol (30d)7.42K
Avg Vol (10d)11.42K
Technical Indicators
RSI (14)47.8
MACD-0.2946
MACD Signal-0.7410
MACD Hist.+0.4464
BB Upper72.60 EUR
BB Middle70.10 EUR
BB Lower67.60 EUR
BB Width7.13%
ATR (14)1.387 EUR
Vol Ratio (20d)1.48x